Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,471,670
+$919,126 QoQ
Shares Held
72,417
+4.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#273
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mutual Advisors, LLC holds $138,410,834 across 12 Drug Manufacturers - General names. NVO ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,768 | $82,482,409 | |
| 2 | JNJ |
Johnson & Johnson
|
56,927 | $14,457,750 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,606 | $10,100,871 | |
| 4 | ABBV |
AbbVie Inc.
|
33,603 | $8,455,858 | |
| 5 | PFE |
Pfizer Inc
|
250,040 | $6,020,963 | |
| 6 | AMGN |
Amgen Inc
|
13,560 | $4,910,347 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
72,417 | $3,471,670 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,689 | $2,866,528 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,471,670 | 72,417 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,552,544 | 69,457 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,468,850 | 48,523 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,640,769 | 47,590 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,127,848 | 45,318 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,628,234 | 37,849 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,428,086 | 28,227 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,755,944 | 31,544 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $4,235,524 | 29,673 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,503,907 | 27,289 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,730,562 | 26,395 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,276,410 | 25,032 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,430,039 | 15,016 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,169,237 | 13,631 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,287,246 | 16,900 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,768,033 | 17,746 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $521,158 | 4,677 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $532,262 | 4,793 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $454,608 | 4,059 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $305,503 | 3,182 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $306,765 | 3,662 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $241,026 | 3,575 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,067,866 | 15,288 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,352,010 | 19,473 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,321,517 | 20,182 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $325,983 | 5,415 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||